Additive Effect of Qidan Dihuang Grain, a Traditional Chinese Medicine, and Angiotensin Receptor Blockers on Albuminuria Levels in Patients with Diabetic Nephropathy: A Randomized, Parallel-Controlled Trial

Table 5

The results of the two groups on the further efficacy and safety variables.

	Treatment group	Control group	value
	()	()
SBP (mmHg)	119.00 (115.00, 127.00)	119.00 (109.25, 127.00)	0.415
DBP (mmHg)	78.00 (75.00, 80.00)	76.00 (72.00, 80.00)	0.111
HbA1c (%)	7.67 ± 0.24	7.50 ± 0.20	0.066
AST (μ/L)	20.00 (16.00, 25.00)	18.50 (16.00, 23.75)	0.650
ALT (μ/L)	18.0 (14.00, 26.00)	19.50 (15.25, 24.50)	0.827
BUN (mmol/L)	5.19 ± 0.18	5.13 ± 0.24	0.832
Scr (μmol/L)	63.00 (56.00, 75.00)	62.00 (54.25, 80.75)	0.921
HDL (mmol/L)	1.23 (1.11, 1.46)	1.20 (0.99, 1.65)	0.586
LDL (mmol/L)	2.58 ± 0.10	2.77 ± 0.16	0.296
TG (mmol/L)	1.22 (0.87, 1.56)	1.14 (0.53, 1.80)	0.984
TC (mmol/L)	4.44 ± 0.13	4.67 ± 0.17	0.136

Data are expressed as the mean ± SD for normal distribution. Nonnormally distributed values are presented as median (interquartile range). values represent the treatment group versus the control group. represent versus baseline (week 0), paired -test for normal distribution or Wilcoxon matched-pairs signed-rank test for nonnormal distribution. SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate transaminase. ALT, alanine transaminase; BUN, blood urea nitrogen; Scr, serum creatinine; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol.